These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17125274)

  • 1. Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.
    McGuigan C; Hassan-Abdallah A; Srinivasan S; Wang Y; Siddiqui A; Daluge SM; Gudmundsson KS; Zhou H; McLean EW; Peckham JP; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; Balzarini J
    J Med Chem; 2006 Nov; 49(24):7215-26. PubMed ID: 17125274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency.
    McGuigan C; Harris SA; Daluge SM; Gudmundsson KS; McLean EW; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; De Clercq E; Balzarini J
    J Med Chem; 2005 May; 48(10):3504-15. PubMed ID: 15887959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus.
    Perrone P; Daverio F; Valente R; Rajyaguru S; Martin JA; Lévêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
    J Med Chem; 2007 Nov; 50(22):5463-70. PubMed ID: 17914786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoramidate protides of carbocyclic 2',3'-dideoxy-2',3'-didehydro-7-deazaadenosine with potent activity against HIV and HBV.
    Gudmundsson KS; Wang Z; Daluge SM; Johnson LC; Hazen R; Condreay LD; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1929-37. PubMed ID: 15628749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric synthesis and antiviral activities of L-carbocyclic 2', 3'-didehydro-2',3'-dideoxy and 2',3'-dideoxy nucleosides.
    Wang P; Gullen B; Newton MG; Cheng YC; Schinazi RF; Chu CK
    J Med Chem; 1999 Aug; 42(17):3390-9. PubMed ID: 10464025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
    Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
    J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (Z)- and (E)-2-((hydroxymethyl)cyclopropylidene)methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity.
    Qiu YL; Ksebati MB; Ptak RG; Fan BY; Breitenbach JM; Lin JS; Cheng YC; Kern ER; Drach JC; Zemlicka J
    J Med Chem; 1998 Jan; 41(1):10-23. PubMed ID: 9438017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties.
    McGuigan C; Gilles A; Madela K; Aljarah M; Holl S; Jones S; Vernachio J; Hutchins J; Ames B; Bryant KD; Gorovits E; Ganguly B; Hunley D; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters R; Wang J; Chamberlain S; Henson G
    J Med Chem; 2010 Jul; 53(13):4949-57. PubMed ID: 20527890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of substituents on the aryl moiety of the aryl phosphoramidate derivative of d4T enhances anti-HIV efficacy in cell culture: A structure-activity relationship.
    Siddiqui AQ; Ballatore C; McGuigan C; De Clercq E; Balzarini J
    J Med Chem; 1999 Feb; 42(3):393-9. PubMed ID: 9986709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system.
    Meier C; Knispel T; De Clercq E; Balzarini J
    J Med Chem; 1999 May; 42(9):1604-14. PubMed ID: 10229629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoramidate protides of 2',3'-dideoxy-3'-fluoroadenosine and related nucleosides with potent activity against HIV and HBV.
    Gudmundsson KS; Daluge SM; Johnson LC; Jansen R; Hazen R; Condreay LD; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1953-61. PubMed ID: 14609234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antiviral activity, and mechanism of drug resistance of D- and L-2',3'-didehydro-2',3'-dideoxy-2'-fluorocarbocyclic nucleosides.
    Wang J; Jin Y; Rapp KL; Bennett M; Schinazi RF; Chu CK
    J Med Chem; 2005 Jun; 48(11):3736-48. PubMed ID: 15916425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-HIV and anti-HBV activities of 2'-fluoro-2', 3'-unsaturated L-nucleosides.
    Lee K; Choi Y; Gullen E; Schlueter-Wirtz S; Schinazi RF; Cheng YC; Chu CK
    J Med Chem; 1999 Apr; 42(7):1320-8. PubMed ID: 10197975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus.
    Uckun FM; Pendergrass S; Qazi S; Samuel P; Venkatachalam TK
    Eur J Med Chem; 2004 Mar; 39(3):225-34. PubMed ID: 15051170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent nonclassical nucleoside antiviral drugs based on the N,N-diarylformamidine concept.
    Anastasi C; Hantz O; De Clercq E; Pannecouque C; Clayette P; Dereuddre-Bosquet N; Dormont D; Gondois-Rey F; Hirsch I; Kraus JL
    J Med Chem; 2004 Feb; 47(5):1183-92. PubMed ID: 14971898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral evaluation of unnatural beta-L-enantiomers of 3'-fluoro- and 3'-azido-2',3'-dideoxyguanosine derivatives.
    Marchand A; Mathé C; Imbach JL; Gosselin G
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):205-17. PubMed ID: 10772710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehydrothymidine monophosphate.
    Roman CA; Balzarini J; Meier C
    J Med Chem; 2010 Nov; 53(21):7675-81. PubMed ID: 20945915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic properties of the unnatural beta-L-enantiomers of 2',3'-dideoxyadenosine and 2',3'-didehydro-2',3'-dideoxyadenosine.
    Pélicano H; Pierra C; Eriksson S; Gosselin G; Imbach JL; Maury G
    J Med Chem; 1997 Nov; 40(24):3969-73. PubMed ID: 9397178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the anti-hepatitis B virus activity of (+)-5'-noraristeromycin exist in its 4'-epimer and 4'-deoxygenated derivatives?
    Seley KL; Schneller SW; Korba B
    J Med Chem; 1998 Jun; 41(12):2168-70. PubMed ID: 9622558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
    McGuigan C; Perrone P; Madela K; Neyts J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.